Eomesodermin, a target gene of Pou4f2, is required for retinal ganglion cell and optic nerve development in the mouse.
The mechanisms regulating retinal ganglion cell (RGC) development are crucial for retinogenesis and for the establishment of normal vision. However, these mechanisms are only vaguely understood. RGCs are the first neuronal lineage to segregate from pluripotent progenitors in the developing retina. As output neurons, RGCs display developmental features very distinct from those of the other retinal cell types. To better understand RGC development, we have previously constructed a gene regulatory network featuring a hierarchical cascade of transcription factors that ultimately controls the expression of downstream effector genes. This has revealed the existence of a Pou domain transcription factor, Pou4f2, that occupies a key node in the RGC gene regulatory network and that is essential for RGC differentiation. However, little is known about the genes that connect upstream regulatory genes, such as Pou4f2 with downstream effector genes responsible for RGC differentiation. The purpose of this study was to characterize the retinal function of eomesodermin (Eomes), a T-box transcription factor with previously unsuspected roles in retinogenesis. We show that Eomes is expressed in developing RGCs and is a mediator of Pou4f2 function. Pou4f2 directly regulates Eomes expression through a cis-regulatory element within a conserved retinal enhancer. Deleting Eomes in the developing retina causes defects reminiscent of those in Pou4f2(-/-) retinas. Moreover, myelin ensheathment in the optic nerves of Eomes(-/-) embryos is severely impaired, suggesting that Eomes regulates this process. We conclude that Eomes is a crucial regulator positioned immediately downstream of Pou4f2 and is required for RGC differentiation and optic nerve development.
Mao
Chai-An
CA
Department of Biochemistry and Molecular Biology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.
Kiyama
Takae
T
Pan
Ping
P
Furuta
Yasuhide
Y
Hadjantonakis
Anna-Katerina
AK
Klein
William H
WH
D000483:Alleles; D000818:Animals; D001369:Axons; D001483:Base Sequence; D001665:Binding Sites; D016923:Cell Death; D017124:Conserved Sequence; D024202:Electrophoretic Mobility Shift Assay; D004622:Embryo, Mammalian / Q000166:cytology / Q000378:metabolism; D004742:Enhancer Elements, Genetic / Q000235:genetics; D005260:Female; D018507:Gene Expression Regulation, Developmental; D018390:Gene Targeting; D018398:Homeodomain Proteins / Q000378:metabolism*; D006801:Humans; D008297:Male; D051379:Mice; D008969:Molecular Sequence Data; D009186:Myelin Sheath / Q000378:metabolism; D009900:Optic Nerve / Q000166:cytology / Q000196:embryology* / Q000378:metabolism; D010802:Phylogeny; D012165:Retinal Ganglion Cells / Q000166:cytology* / Q000378:metabolism; D020825:T-Box Domain Proteins / Q000235:genetics*; D050820:Transcription Factor Brn-3B / Q000378:metabolism*; D014158:Transcription, Genetic
C491198:Eomes protein, mouse; D018398:Homeodomain Proteins; C085559:Pou4f2 protein, mouse; D020825:T-Box Domain Proteins; D050820:Transcription Factor Brn-3B